DATROWAY approved in the EU for patients with previously treated metastatic HR positive, HER2 negative...

ALX Oncology receives IND clearance from U.S. FDA for ALX2004, a novel EGFR-targeted antibody-drug conjugate

IDEAYA Biosciences announces Phase 1/2 expansion for IDE397 and Trodelvy combination in MTAP-deletion urothelial cancer

Novelty Nobility, selected by JLABS Korea, hosted by Johnson & Johnson

OS Therapies completes acquisition of Advaxis Immunotherapies clinical, pre-clinical and IP assets from Ayala Pharmaceuticals

Backing from BioNTech powers ADC specialist DualityBio toward $200M Hong Kong IPO